BioCentury
ARTICLE | Company News

UroCor, Prostate Services of America sales and marketing update

November 8, 1999 8:00 AM UTC

Prostate Services will market to its customer base UCOR's ProstaSeed I-125 radiation treatment for prostate cancer. ProstaSeed, which has received FDA 510(k) clearance, also is awaiting approval by th...